Background: The increasing prevalence of multidrug-resistant Pseudomonas aeruginosa limits treatment options and highlights the need for new antimicrobials. Although agents such as ceftazidime-avibactam (CZA), ceftolozane-tazobac... ...

请注册登录后继续浏览